Observatory of Unintentional Births Hospital Extras (AIEH34)

March 9, 2020 updated by: University Hospital, Montpellier

Observatory of Unintentional Births Hospital Extras in Hérault

In France, pre-hospital unexpected birth is a rare situation, but over the last ten years, the investigators have seen an increase in the number of these.

For this, the investigators realize an observatory of these deliveries and their care from the call for help and the investigators continue the follow-up and the future of patients and newborns until J7 postpartum.

Study Overview

Status

Unknown

Detailed Description

As a result, the investigators also found a very high variability in the number of deliveries per month for the EMS 34 and the SSSM of the SDIS 34, which can reach up to 11 deliveries per month (May 2014 example).

Formalized expert recommendations were published in 2010 by SFAR, which then led to the establishment of a national observatory for IEA at the end of 2011, in which the investigators have been participating for 4 years.

Currently the national database lists 2000 unannounced deliveries including 230 in the Hérault.

This observational study allows us to evaluate the management of these patients and newborns, the risks and needs of pre-hospital teams, including the need for reinforcement and expertise of midwives.

The investigators can also assess mortality and morbidity, as well as the extension of hospital stays beyond J7

Study Type

Observational

Enrollment (Anticipated)

350

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Montpellier, France, 34295

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Unexpected delivery outside maternity in the Hérault department

Description

Inclusion Criteria:

  • Unexpected delivery outside maternity, presence of a medical team during the care

Exclusion Criteria:

  • Absence of medicalization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of unexpected hospital deliveries (AIE)
Time Frame: DAY 0 TO DAY 7 TO DELIVRERY
Estimate the impact of non-maternal AIE by the SMUR and the SSM in the department of Héraul, and compare it to the national overall activity
DAY 0 TO DAY 7 TO DELIVRERY

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Method of taking care of unannounced extra hospital deliveries
Time Frame: DAY 0 TO DAY 7 POST DELIVRERY
Method of taking care of unannounced extra hospital deliveries
DAY 0 TO DAY 7 POST DELIVRERY
Difficulties during an unexpected delivery outside maternity
Time Frame: DAY 0 TO DAY 7 POST DELIVRERY
Identify the difficulties during an unexpected delivery outside maternity
DAY 0 TO DAY 7 POST DELIVRERY
Risks during an unexpected delivery outside maternity
Time Frame: DAY 0 TO DAY 7 POST DELIVRERY
Identify the risks during an unexpected delivery outside maternity
DAY 0 TO DAY 7 POST DELIVRERY
Possible immediate complications during an unexpected delivery outside maternity
Time Frame: DAY 0 TO DAY 7 POST DELIVRERY
Identify the possible immediate complications during an unexpected delivery outside maternity
DAY 0 TO DAY 7 POST DELIVRERY

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christelle GRAF, wise woman, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 23, 2019

Primary Completion (Anticipated)

February 1, 2022

Study Completion (Anticipated)

February 28, 2022

Study Registration Dates

First Submitted

January 23, 2019

First Submitted That Met QC Criteria

January 25, 2019

First Posted (Actual)

January 29, 2019

Study Record Updates

Last Update Posted (Actual)

March 10, 2020

Last Update Submitted That Met QC Criteria

March 9, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

3
Subscribe